Manager/Senior Manager, Non-Clinical Operations (Contract Role)
ContractSeniorTranslational Science and Clinical BiomarkersGene TherapyGene Therapy
Description
Role Summary
The Translational Science and Clinical Biomarker (TSCB) team is comprised of drug development scientists representing pharmacology, toxicology, non-clinical bioanalytics and clinical biomarker development and operational support. The Manager/Sr. Manager, Non-Clinical Operations position will support operational oversight and conduct of outsourced small and large animal non-clinical studies at contract research organizations (CROs) related to AAV-based gene therapy for cardiac disorders. Key functions of the position include direct interactions with preclinical CROs, qualification of vendors, oversight and coordination of study logistics (e.g., contracts, test articles, study records, etc.), and monitoring of non-clinical studies at specific milestones. Importantly, this position will interface with Medical Writing and liaise with contractors to manage authoring and review of non-clinical study reports and non-clinical sections/modules of regulatory documents such as pre-INDs and INDs.
<div><strong>About Lexeo</strong></div>
<div> </div>
<div>Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact. </div>
<div> </div>
<div>Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.</div>
<div> </div>
<div><strong>Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.</strong></div>
Lexeo Therapeutics
BIOTECHNOLOGY
Gene Therapy
LocationNY - New York
Open Jobs10
Gene Therapy
View Company ProfilePipeline
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients WiN/A
Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 PN/A
Clinical Course Of Disease In Participants With FA-CMN/A
LX1001Phase 1
LX1001Phase 1/2